Tap into your
brain’s power to
take on depression symptoms

Yes. Unlike wellness apps, Rejoyn is classified as a medical device and was authorized by the FDA after being studied in a phase 3 clinical trial. It requires a prescription from a healthcare provider. Start a virtual consult to get a prescription.

Rejoyn was effective in a clinical trial of adults age 22+ with major depressive disorder, also known as depression, who were also taking an antidepressant medication. After they finished the 6-week program, the effect of Rejoyn was measured. Results showed that using Rejoyn reduced depression symptoms. On average, people reported that Rejoyn reduced their depression severity from moderately severe to mild,* and clinicians reported that Rejoyn reduced depression severity from moderately ill to mildly ill.^† During the month following treatment with Rejoyn, there was a trend toward continued improvement. Learn more about results with Rejoyn.

^*Measured by a participant-reported outcome scale of depression, Patient Health Questionnaire (PHQ-9). In the control arm, people using a Sham app reported reduced depression severity from moderately severe to moderate.

^†Measured by a clinician-reported outcome scale of depression, Clinical Global Impressions-Severity Scale (CGI-S).

We are committed to protecting the privacy and security of your information. We may use and share your data for the purposes described in our Privacy Notice and in a manner consistent with your privacy choices. Once you start treatment, you can change some of your privacy choices under "Privacy choices" by tapping the profile icon in the main menu, or calling 1-833-Y-REJOYN (1-833-973-5696) for additional support. Available Monday through Friday, 8 _AM to 8 _PM ET, excluding holidays.